No Data
Hong Kong stock market activity | IMMUNEONCO-B (01541) rose nearly 15% in the morning, planning to sell Shanghai industrial land for 98.19 million yuan, which will help strengthen the company's Cash / Money Market.
IMMUNEONCO-B (01541) rose nearly 15% in the early session. As of the time of writing, it is up 14.47%, priced at HKD 5.38, with a trading volume of HKD 96.8599 million.
ImmuneOnco: Disposal to Strengthen Cash Flow, Improve Liquidity
ImmuneOnco: Expect Gross Proceeds of CNY71.5M-CNY98.2M
IMMUNEONCO-B (01541) sold Shanghai land for approximately 98.19 million yuan, expecting a loss of up to 2.74 million yuan.
Jinwu Financial News | IMMUNEONCO-B (01541) announced the sale of all shares of Shanghai Zhangtouyao New Technology Development for approximately 98.19 million yuan (RMB, the same below) to Shanghai Zhangjiang (Group), with expected losses between 0.7 million and 2.74 million yuan. According to the announcement, Shanghai Zhangtouyao New Technology holds industrial land in the Kangqiao Industrial Park of Pudong New District, Shanghai, with an area of approximately 0.028 million square meters. Apart from the completed pile foundation work, no construction has been carried out on the land at present. The group stated that after the sale is finalized, cash flow will be strengthened, and the proceeds from the sale are intended to be used for general working capital.
IMMUNEONCO-B (01541) plans to sell all of its equity in Shanghai Zhangtouyao New Technology Development.
IMMUNEONCO-B (01541) announced that on December 30, 2024 (after trading hours), the company and...
Express News | ImmuneOnco Biopharmaceuticals Shanghai Inc - Disposal of Stake in Unit
